Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model

Chih Peng Chang, Ming Cheng Yang, Hsiao Sheng Liu, Yee Shin Lin, Huan Yao Lei

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Concanavalin A (ConA), a lectin with mannose specificity that can induce acute hepatic inflammation, was tested for its therapeutic effect against hepatoma. ConA is cytotoxic or inhibitory to hepatoma cells, which is mediated by the autophagic pathway through mitochondria. Once it was bound to cell membrane glycoproteins, the ConA was internalized and preferentially localized onto the mitochondria. The mitochondria membrane permeability changed, and an autophagic pathway including LC3-II generation, double-layer vesicle, BNIP3 induction, and acidic vesicular organelle formation was induced. Either 3-MA or siRNA for BNIP3 and LC3, but neither beclin-1 nor ATG 5, partially inhibited the ConA-induced cell death. In addition to the autophagy induction, ConA is known to be a T cell mitogen. Using an in situ hepatoma model, ConA can exert an anti-hepatoma therapeutic effect, inhibiting tumor nodule formation in the liver and prolonging survival. Conclusion: ConA can be considered as an anti-hepatoma agent therapeutically because of its autophagic induction and immunomodulating activity. This dual function of ConA provides a novel mechanism for the biological effect of lectin.

Original languageEnglish
Pages (from-to)286-296
Number of pages11
JournalHepatology
Volume45
Issue number2
DOIs
Publication statusPublished - 2007 Feb 1

Fingerprint

Autophagy
Therapeutic Uses
Concanavalin A
Hepatocellular Carcinoma
Mitochondria
Lectins
Liver
Membrane Glycoproteins
Mannose
Mitogens
Organelles
Small Interfering RNA
Permeability
Cell Death
Cell Membrane
Inflammation
T-Lymphocytes
Membranes

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

@article{c117ef3594a44af78e502fa704c50c67,
title = "Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model",
abstract = "Concanavalin A (ConA), a lectin with mannose specificity that can induce acute hepatic inflammation, was tested for its therapeutic effect against hepatoma. ConA is cytotoxic or inhibitory to hepatoma cells, which is mediated by the autophagic pathway through mitochondria. Once it was bound to cell membrane glycoproteins, the ConA was internalized and preferentially localized onto the mitochondria. The mitochondria membrane permeability changed, and an autophagic pathway including LC3-II generation, double-layer vesicle, BNIP3 induction, and acidic vesicular organelle formation was induced. Either 3-MA or siRNA for BNIP3 and LC3, but neither beclin-1 nor ATG 5, partially inhibited the ConA-induced cell death. In addition to the autophagy induction, ConA is known to be a T cell mitogen. Using an in situ hepatoma model, ConA can exert an anti-hepatoma therapeutic effect, inhibiting tumor nodule formation in the liver and prolonging survival. Conclusion: ConA can be considered as an anti-hepatoma agent therapeutically because of its autophagic induction and immunomodulating activity. This dual function of ConA provides a novel mechanism for the biological effect of lectin.",
author = "Chang, {Chih Peng} and Yang, {Ming Cheng} and Liu, {Hsiao Sheng} and Lin, {Yee Shin} and Lei, {Huan Yao}",
year = "2007",
month = "2",
day = "1",
doi = "10.1002/hep.21509",
language = "English",
volume = "45",
pages = "286--296",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. / Chang, Chih Peng; Yang, Ming Cheng; Liu, Hsiao Sheng; Lin, Yee Shin; Lei, Huan Yao.

In: Hepatology, Vol. 45, No. 2, 01.02.2007, p. 286-296.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model

AU - Chang, Chih Peng

AU - Yang, Ming Cheng

AU - Liu, Hsiao Sheng

AU - Lin, Yee Shin

AU - Lei, Huan Yao

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Concanavalin A (ConA), a lectin with mannose specificity that can induce acute hepatic inflammation, was tested for its therapeutic effect against hepatoma. ConA is cytotoxic or inhibitory to hepatoma cells, which is mediated by the autophagic pathway through mitochondria. Once it was bound to cell membrane glycoproteins, the ConA was internalized and preferentially localized onto the mitochondria. The mitochondria membrane permeability changed, and an autophagic pathway including LC3-II generation, double-layer vesicle, BNIP3 induction, and acidic vesicular organelle formation was induced. Either 3-MA or siRNA for BNIP3 and LC3, but neither beclin-1 nor ATG 5, partially inhibited the ConA-induced cell death. In addition to the autophagy induction, ConA is known to be a T cell mitogen. Using an in situ hepatoma model, ConA can exert an anti-hepatoma therapeutic effect, inhibiting tumor nodule formation in the liver and prolonging survival. Conclusion: ConA can be considered as an anti-hepatoma agent therapeutically because of its autophagic induction and immunomodulating activity. This dual function of ConA provides a novel mechanism for the biological effect of lectin.

AB - Concanavalin A (ConA), a lectin with mannose specificity that can induce acute hepatic inflammation, was tested for its therapeutic effect against hepatoma. ConA is cytotoxic or inhibitory to hepatoma cells, which is mediated by the autophagic pathway through mitochondria. Once it was bound to cell membrane glycoproteins, the ConA was internalized and preferentially localized onto the mitochondria. The mitochondria membrane permeability changed, and an autophagic pathway including LC3-II generation, double-layer vesicle, BNIP3 induction, and acidic vesicular organelle formation was induced. Either 3-MA or siRNA for BNIP3 and LC3, but neither beclin-1 nor ATG 5, partially inhibited the ConA-induced cell death. In addition to the autophagy induction, ConA is known to be a T cell mitogen. Using an in situ hepatoma model, ConA can exert an anti-hepatoma therapeutic effect, inhibiting tumor nodule formation in the liver and prolonging survival. Conclusion: ConA can be considered as an anti-hepatoma agent therapeutically because of its autophagic induction and immunomodulating activity. This dual function of ConA provides a novel mechanism for the biological effect of lectin.

UR - http://www.scopus.com/inward/record.url?scp=33847754341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847754341&partnerID=8YFLogxK

U2 - 10.1002/hep.21509

DO - 10.1002/hep.21509

M3 - Article

C2 - 17256764

AN - SCOPUS:33847754341

VL - 45

SP - 286

EP - 296

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -